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           Charles Darwin University 
                    Final Examination  
 
 
PHA312 – Infectious Diseases 
DURATION 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
The examination has TWO (A and B) Sections: 
  
Section A contains short essay questions: Answer All questions. Total marks allocated: 75 
Suggested time allocation: Ninety (90) minutes  
 
Section B contains case studies questions: Answer All questions. Total marks allocated: 75 
Suggested time allocation: Ninety (90) minutes  
 
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
Any non-programmable calculator is permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 




1 x 8 Page Book 
1 x 20 Page Book 
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Section A 
Short Answer Questions 
Answer All Questions 
Total No of Marks for this Section:  75 
 
 
This section should be answered on the 20-page Answer Booklet provided.  Please ensure that your 
name and student number have been written on the completed Answer Booklet. 
 
Marks for each question are indicated.  Suggested time allocation for Section A:  90 mins 
 
 
Question 1  
 
Briefly discuss the mode of action, spectrum of antimicrobial activity and any special considerations for 
use of any THREE of the following antimicrobial agents:  
 





 (Marks 5 + 5 + 5 = 15) 
Question 2 
 
Briefly discuss the mechanisms by which microorganisms develop resistance to any THREE of the 


















 Semester 2, 2017 FINAL EXAMINATION Page 4 of 13  
PHA312 – Infectious Diseases 
 
THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM ANY EXAMINATION VENUE IN ANY 




Briefly discuss the pathogenesis and key management principles of pharyngitis. 
(Pathogenesis should include common pathogens, risk factors and prognosis.) 
 
 






Outline the factors that are important in selecting antimicrobials to treat central nervous system 
infections, giving relevant examples. 







Question 5  
 
a. Briefly discuss the pathogenesis of infectious endocarditis. 
b. Suggest a first line empirical regimen for infectious endocarditis, and justify your choice.  
 
 








a. Briefly discuss the pathogenesis of Clostridium difficile Infection (CDI). 
b. Outline the approach to the management of this condition. 
 
 
 (Marks 5 + 10 = 15)  
 
 
END OF SECTION A 
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Section B 
Case Study Questions 
Answer all questions 
Total No of Marks for this Section: 75  
 
This section should be answered in the Answer Booklet provided. 
 




A 68 years old male living on a remote station has been referred, complaining of pain in the right leg 
associated with a wound oozing pus for 6 months.  He was involved in a road traffic accident, in which 
he sustained an open fracture to the right tibia 6 months ago. He was treated for the fracture in hospital 
and discharged 3 months ago. 
He has a history of type II DM, hypertension and chronic kidney disease.  
He has had at least two courses of antibiotics (flucloxacillin) from his local GP. 




A. Discuss the pathogenesis of osteomyelitis in this patient. 
(Discussion of pathogenesis should include relevant risk factors, pathogens and prognosis of the 
infection.) 
(Marks: 5) 
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The pus MCS result has become available: 
Organism: Staphylococcus aureus +++  
 
Drug Susceptibility  
Amoxicillin/Clavulanic acid  R 
Clindamycin  I 
Cephalotin  R 
Flucloxacillin   R 
Rifampicin  S 
Ticarcillin  I 
Vancomycin  S 
 
Susceptibilities (S = susceptible; R = resistant; I = intermediate; N = not performed) 
The doctor decides to change his antibiotic therapy to IV vancomycin 2 g daily, with a target trough level 
of 10-15 mcg/mL.  
Three days after the initiation of new antibiotic, his pre- and post-vancomycin levels and other test 
results are: 
Date  26/07  22/07  04/03  01/03  18/02  
Cr (umol/L)  123  93  98  84  106  
eGFR  51  70  66  79  60  
ALT  19  22  
Vancomycin (mcg/mL)  18  
 
 
C. Taking his condition into consideration and the laboratory findings, what would be your 
recommendation regarding the vancomycin use in this patient? Justify your recommendation and 
outline any additional monitoring that may be required.  
 
Patient Height: 162 cm 
Patient Weight: 61 kg 
 
(Marks 15)  
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Case 2  
A 75-year old female presents to hospital upon experiencing influenza-like symptoms and generally 
feeling unwell for one week. She has non-productive cough and describes pain in her chest. 
 She has a past medical history of hypertension and high cholesterol, diagnosed 20 years ago; she 
suffered from a mild stroke 2 years ago, which has left her with slurred speech. She also has arthritis in 
both knees.  Her current regular medications include Ramipril, low dose aspirin, atorvastatin, 
paracetamol and oxycodone. 
She lives in her own home independently but requires assistance with some activities of daily living such 
as shopping and cleaning. 
 
 
On examination, she is found to be moderately dehydrated. Physical examination and chest X-ray (CXR) 
show evidence of right middle lobe consolidation but the remainder of the chest is clear. Vital signs are 
as follows: 
 
BP = 118/63 
HR 90 bpm 
RR 18 breath/min 
Temperature 37.4°C 




Full Blood Count U/E 
RCC 4.05 Na 134  
Plt 168 K 3.6  
WCC 14.2 eGFR 37  
neutrophil 11.90 CRP 280 
Lymphocytes 0.65   
Monocytes 0.13   
 
A sputum sample is collected and sent for MCS testing. Preliminary results indicated a mixed growth and 
normal oral flora. A second sputum sample was ordered.  
 











 Semester 2, 2017 FINAL EXAMINATION Page 8 of 13  
PHA312 – Infectious Diseases 
 
THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM ANY EXAMINATION VENUE IN ANY 




A. Briefly discuss the severity of her condition with reference to specific parameters. 
 (Marks 5)  
 
B. Briefly describe the pathogenesis of pneumonia in this patient.  




C. What empirical therapy would you recommend for the treatment of this patient? (Your answer 
should also include the rationale for your recommendation and any specific considerations.)  
(Marks 5)  
 
Three days after the initiation of empirical therapy, the symptoms of pneumonia are improving, and the 
second sputum MCS test finds no growth after 48 hours.  
However, the patient develops a sudden onset of painful skin rash on the right side of her chest. She is 
diagnosed with shingles.  
 
Questions  
D. Discuss the pathogenesis of shingles in this patient. 
(Discussion of pathogenesis should include route of infection, risk factors and pathogens involved.) 
 
(Marks: 5)  
 
E. Outline the treatment plan you would recommend for managing the shingles.  
(Your answer should also include the rationale for your recommendation and any specific 
considerations.) 
 
(Marks: 5)  
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Case 3  
A 33-year old female presents to her GP complaining of pain during urination (dysuria) and lower 
abdominal pain for 2 days. She has a history of recurrent urinary tract infections. 
She has type I diabetes diagnosed when she was 15 years old. Her diabetes is well controlled by insulin 
and lifestyle modifications. She is allergic to penicillin (severe rash and laryngeal oedema develop if she 
is exposed to chemically related agents.) 
She cannot recall the date of her last menstrual period; a home pregnancy test done 2 days ago was 
positive. 
 
On examination, the patient is visibly uncomfortable but afebrile to touch.  BP = 134/68, HR 81 bpm. 
 
Urine dipstick test:  
 





RBC negative  
 
She is diagnosed with cystitis. Empirical therapy was commenced with cephalexin 
 
Questions  




B. Outline a management plan (further investigations, treatment and prophylaxis) that you would 
recommend for this patient.  
 
 (Marks 10) 
 
 





D. What follow up would you suggest for the patient? 
(Marks 5) 
 
 (Total: 25 marks) 
END OF EXAM 
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Reference Ranges  
Urea and electrolytes (U&E) 
Na 135.0-145.0 mmol/L 
K 3.50-4.50 mmol/L (plasma)   
3.8-4.9 mmol/L (serum) 
Cl 95-110 mmol/L 
Urea 3.8-8.0 mmol/L 
Creatinine 60-100 micromol/L 
eGFR > 90 mL/min/1.73 m2 
Osmolality (serum) 275-295 mOsm/kg 
Anion gap 13-17 mEq/L 
 
Calcium, magnesium and phosphate (CMP) 
Ca (total) 2.1-2.6 mmol/L 
Ca (ionised) 1.16-1.3 mmol/L 
PO43- 0.8-1.5 mmol/L 
Mg 0.8-1.0 mmol/L 
 
Arterial blood gas (ABG) 
pH 7.35-7.45 
pO2 80-110 mmHg 
pCO2 35-45 mmHg 
Bicarbonate (HCO3-) 22-33 mmol/L 
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Liver function test (LFT) 
ALT <30 U/L 
AST <40 U/L 
ALP 30-100 U/L 
GGT <30 U/L (female) 
<50 U/L (male) 
Bilirubin (total) <20 umol/L 
Bilirubin (conjugated) <4.0 umol/L 
Albumin 32-45 g/L 
Total protein 63-80 g/L 
Pancreatic lipase 8 – 78 U/L 
 
Carbohydrate metabolism 
BSL (random) 3.0-7.7 mmol/L 
BSL (fasting) 3.0-5.5 mmol/L 
HbA1c(non-DM) 4.3-5.7% (NGSP) 
23-39 mmol/mol (IFCC) 
HbA1c (DM) therapeutic target<7% * 
 
Fasting lipid biochemistry 
Total cholesterol <5.5 mmol/L 
LDL 2-3.4 mmol/L 
HDL >1 mmol/L 
Non-HDL cholesterol <2.5 mmol/L 
Triglyceride (TG) <1.7 mmol/L 
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Full blood examination (FBE) 
Hb 140-174 g/L (male) 
120-160 g/L (female)  
RCC 4.50-5.50 x1012/L (male) 
4.0- 5.0 x1012/L (female)  
Haematocrit 0.42-0.52 or 42-52 % (male) 
0.36-0.48 or 36-48%(female) 
MCV 80.0-100.0 fL 
RDW 11.5-14.5 % 
Platelets 150-450 x109/L) 
WCC 4.0-11.0 (x109 /L) 
Neutrophil 40-80% 
2.0-7.5 x109 /L 
Lymphocytes 20-40% 




0.0-0.4 x109 /L 
Basophils <2% 
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Thyroid function test (TFT) 
TSH 0.4-5.0 mU/L 
T4 (free) 10-25 pmol/ 
T3 (free) 3.0-6.5 pmol/L 
 
Iron Studies 
Serum Iron  227mcg/dL Men 50 to 150mcg/dL 
Women 35-145mcg/dL 
Total Iron Binding Capacity 350 mcg/dL 250-400mcg/dL 
 
Serum Ferritin 4500g/L Men 20-300ng/L 
Women 20-200ng/L 




Troponin T <0.01 μg/L 
CRP <3 mg/L 
D-dimer <500 μg/L 
BNP <20 nmol/L 
 
 
 
 
 
 
 
 
